Austin-Based Healthcare Technology Provider Recognized for Community Impact, Life-Saving Solutions that Protect Patients, Healthcare Workers December 15, 2025 10:55 ET…
MUMBAI, India, Dec. 13, 2025 /PRNewswire/ -- Mumbai's Fine Arts Centre, came alive as the 21st Ryan International Children's Festival…
AHMEDABAD, India, Dec. 12, 2025 /PRNewswire/ -- Anant National University celebrated its 7th Convocation, awarding degrees to 299 students across…
11 december 2025 - In recognition of its progress in reducing its corporate carbon footprint by 30%, the International Olympic…
December 10, 2025 04:00 ET | Source: Igyxos TOURS, France, Dec. 10, 2025 (GLOBE NEWSWIRE) -- Igyxos Biotherapeutics, a biotechnology…
ABU DHABI, UAE, Dec. 9, 2025 /PRNewswire/ -- Abu Dhabi Finance Week (ADFW), the flagship event hosted by ADGM, continued…
Seizure reduction: phase 3 study achieved primary endpoint as fenfluramine demonstrated a statistically significant reduction in countable motor seizure frequency (CMSF)…
93% overall response and 76% complete response rates with median progression-free survival of 18 months in patients with large B-cell…
December 07, 2025 16:00 ET | Source: Wave Life Sciences USA, Inc. CAMBRIDGE, Mass., Dec. 07, 2025 (GLOBE NEWSWIRE) --…
December 06, 2025 17:30 ET | Source: TScan Therapeutics, Inc. Treatment arm continues to demonstrate favorable relapse-free survival (HR=0.50; p=0.23)…